Approval · Notice of Compliance 22173 · 2019
PMS-METHOTREXATE: Notice of Compliance 22173
Issued May 21, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22173
- Date
- May 21, 2019
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Updates to the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-METHOTREXATE | Not yet assigned | — |
Medicinal ingredients
- METHOTREXATE SODIUM 2.5 MG per TAB